Skip to main content
Dra Ainhoa Rosselló Ferrer

Dra. Ainhoa Rosselló Ferrer

Member No.: 070706543

Qualifications and training
  • Degree in Medicine from the University of Lleida, 2000.
  • Medical Specialist in Ophthalmology via MIR by the Virgen Macarena University Hospital of Seville, 2018.
  • Master’s degree in Clinical Ophthalmology, CEU University, 2018.
  • University Expert Degree in Uveitis and Retina, by CEU University, 2018.
  • University Expert Degree in Glaucoma and Pediatric Ocular Pathology, by CEU University, 2018.
  • University Expert Degree in Ocular Pathologies and treatment, by CEU University, 2018.
  • University Expert Degree in Ophthalmologic Surgery, by CEU University, 2018.
  • International Examination in Optics and Refraction, International Council of Ophthalmology (ICO), 2016.
  • International Examination in Basic Science in Ophthalmology, International Council of Ophthalmology (ICO), 2016.
  • European Accreditation in Adult Transthoracic Echocardiography, by the European Society of Cardiology, 2012.
  • Postgraduate Diploma in Statistics in Health Sciences. Autonomous University of Barcelona, 2009.
  • Title of Advanced Life Support Instructor (ALS) in Trauma. National Plan of Cardiopulmonary Resuscitation (CPR) of the Spanish Society of Intensive Care Medicine, Critical Care and Coronary Units (SEMICYUC), 2007.
  • Health data processing. “Statistical Package for Social Science (SPSS)”. Postgraduate course on health data processing. Autonomous University of Barcelona, 2007.
  • Specialist in Intensive Care Medicine via MIR by the Hospital Universitario Son Dureta, (Palma de Mallorca), 2006.
  • SVA Instructor Title. SEMICYUC National CPR Plan, 2004.
Career path
  • Ophthalmologist at Oftalmedic Salvà since 2022.
  • Attending physician at the Ophthalmology Department of the Hospital Universitario Son Llàtzer. Vitreoretinal Section, 2019-present.
  • Attending physician at the Ophthalmology Department of the Hospital Universitario Son Espases (Palma de Mallorca), 2019.
  • Assistant physician of the Ophthalmology Service of the Hospital de Manacor, 2018.
  • Resident physician at the Ophthalmology Department of the Hospital Universitario Virgen Macarena (HUVM) (Seville), 2014-2018.
  • Estancia en el Institut de Microcirugia Ocular (Barcelona), 2017.
  • Rotatory at the Retina Unit of the Hospital Universitario Son Espases (HUSE) (Palma de Mallorca), 2016.
  • Attending physician of the Department of Intensive Care Medicine and Coronary Unit. University Hospital Son Dureta/Son Espases (Palma de Mallorca), 2006-2014.
  • Resident physician in the Department of Intensive Care Medicine and Coronary Unit. Son Dureta University Hospital (Palma de Mallorca), 2001-2005.
Scientific activities
  • “Quantification of foveal avascular zone area and macular vascular density changes in papilledema by swept-source optical coherence tomography angiography”. Antonio M. Garrido-Hermosilla, Ainhoa Rosselló-Ferrer, Mariola Méndez- Muros & María J. Díaz-Granda. International Journal of Neuroscience. DOI: 10.1080/00207454.2022.2086126.
  • ” YAGhyaloidotomy in premacular subhyaloid hemorrhage. Simple and efficienttechnique “. Clinical cases in Ophthalmology II. Diagnostic problems in retinochoroidal pathology “. ISBN 978-84-16269-41-9. Spanish Retina and VitreousSociety. Gutiérrez Sánchez, E; Rosselló Ferrer, A.
  • “Surgical techniques for cell transplantation in retinal pathology”. Advanced therapies in retinal pathology. Part II. Fundamentals of cell therapy and tissue engineering. Chapter 8. Consuelo Spínola Muñoz, Francisco Espejo Arjona, Lourdes Coca Gutiérrez, Ainhoa Rosselló Ferrer, Belén Domínguez García, Isabel Relimpio López. Communication Requested 91st Congress of the SEO. Seville, 2015.
  • “Treatment of trichiasis in mucosinequiant diseases “. María Concepción Díaz Ruiz, Antonio Manuel Garrido Hermosilla, Rosario Liñán Martínez, Ainhoa Rosselló Ferrer, Rubén Alberto Ángeles Figueroa. Current treatment of mucoconjunctivitis mucosinequiantes keratoconjunctivitis. Jesús Montero Iruzubieta. Communication Requested 91st Congress of the SEO. Sevilla, 2015.
  • ” Orbitalinvolvement and its surgical management in mucosinequiant ophthalmopathies “. Chapter 14. Antonio Manuel Garrido Hermosilla, María Concepción Díaz Ruiz, Ainhoa Rosselló Ferrer, Rubén Alberto Ángeles Figueroa. Current treatment of mucoconjunctivitis mucosinequiantes keratoconjunctivitis. Jesús Montero Iruzubieta. Communication Requested 91st Congress of the SEO. Sevilla, 2015.
  • “Tear involvement and its surgical management in mucosinequiant ophthalmopathies”. Antonio Manuel Garrido Hermosilla, Rosario Liñán Martínez, María Concepción Díaz Ruiz, Ainhoa Rosselló Ferrer, Rubén Alberto Ángeles Figueroa. Current treatment of mucoconjunctivitis mucosinequiantes keratoconjunctivitis. Jesús Montero Iruzubieta. Communication Requested 91st Congress of the SEO. Seville, 2015.
  • ” Surgicaltreatment of conjunctival involvement in mucosinequiant ophthalmopathies “. Chapter 16. Ainhoa Rosselló Ferrer, Antonio Manuel Garrido Hermosilla, María Concepción Díaz Ruiz. Current treatment of mucoconjunctivitis mucosinequiantes keratoconjunctivitis. Jesús Montero Iruzubieta. Communication Requested 91st SEO Congress . Sevilla, 2015.
  • “Surgical treatment in limbic insufficiency of mucosinequiant diseases”. Chapter 17. Ainhoa Rosselló Ferrer, Manuel Caro Magdaleno. Current treatment of mucoconjunctivitis mucosinequiantes keratoconjunctivitis. Jesús Montero Iruzubieta. Communication Requested 91st Congress of the SEO. Seville, 2015.
  • “Updated management of severe caustication”. Rosselló Ferrer, A., Mataix Albert B, García Roldan A. Section 2. Chapter 2.3. Clinical-surgical ophthalmology. From theory to practice. Volume 1. Antonio Manuel Garrido Hermosilla et al. ISBN 978-84-9140-452-1.
  • “Conjunctival melanoma”. Rosselló Ferrer, A., Caro Magdaleno, M, Montero Iruzubieta J. Section 2. Chapter 2.5. Clinical-surgical ophthalmology. From theory to practice. ISBN 978-84-9140-452-1.
  • “Lacrimal gland ductal adenocarcinoma”. Caro Magdaleno, M; Rosselló Ferrer, A; Fernández Villalón JA. Section 2. Chapter 1.10. Clinical-surgical ophthalmology. From theory to practice. ISBN 978-84-9140-452-1.
  • “Acute alcohol intoxication”. Valle J, Rosselló A. JANO.
  • “Neurologic outcome of posttraumatic refractory intracranial hypertension treated with extracraneal lumbar drainage”. Abadal Centellas J, Llompart-Pou JA, Homar-Ramírez J, Pérez-Bárcena J, Rosselló-Ferrer A. The Journal of Trauma. 2007;62 (2).
  • “Patent foramen ovale and mechanical ventilation”. Letter to the editor. Ainhoa Rosselló Ferrer, Antonio Rodríguez Fernández, María Riera Sagrera and Miquel Fiol Sala. Rev Esp Cardiol. 2010; 63 :877-8.
  • “Acute syphilitic posterior placoid posterior chorioretinitis through optical coherence tomography angiography”. Rosselló Ferrer A, Artigues Martínez M., Salvá Palomeque T. 98th National Congress of Ophthalmology. Pamplona, 2022.
  • “Importance of the perifoveal vascular anomalous complex in the differential diagnosis of other macular pathologies”. Rosselló Ferrer A, Salvá Palomeque T., Artigues Martínez M. 98th National Congress of Ophthalmology. Pamplona, 2022.
  • “Acute paracentral median maculopathy and its ischemic progression”. Salvá Palomeque T., Rosselló Ferrer A. Congress of the Spanish Retina and Vitreous Society. Madrid, 2022.
  • “The role of sclerotomies in cataract surgery for glaucoma associated with nanfotalmia”. Rosselló Ferrer A, I. Relimpio, M. Parrilla, M.J. Cano, B. Ponte. Abstract ID: 2180.13th European Glaucoma Society Congress. Florencia, 2018.
  • “Pearls in the surgical management of severe ROP”. Rosselló Ferrer A; Alcántara Peña A; Relimpio López I. Oral communication at the Vitreo-Retinal Symposium, within the L Congress of the Andalusian Society of Ophthalmology (SAO). Granada, 2018.
  • Effectiveness and safety of XEN45 in patients with previous EPNP. Rosselló Ferrer, A.; Llavero Valero, P.; Parrilla Vallejo, M.; Prieto Aberasturi, A.; Cano Gómez, M.J.; Ponte Zúñiga, B.; Relimpio López, I. P147. L Congress of the Andalusian Society of Ophthalmology (SAO). Granada, 2018.
  • “Surgical management of angle-closure glaucoma in the nanophthalmic eye”. Ponte Zuñiga B; Rosselló Ferrer A; Alcántara Peña A; Relimpio López I; Cano Gómez MJ. Accepted for oral communication at the XIII National Congress of the Spanish Glaucoma Society (SEG). Bilbao, 2018.
  • “XEN45 as a rescue treatment “. Cano Gómez MJ; Rosselló Ferrer A; Alcántara Peña A; Parrilla Vallejo M. Accepted for oral communication at the XIII National Congress of the SEG. Bilbao, 2018.
  • “Scleromalacia as the debut of glaucoma after congenital cataract surgery”. Rosselló Ferrer A; López Domínguez M; Torres García FJ; Lledó Villar ML; Serra Castanera A; Espejo Arjona F. Oral communication at the 4th Congress of the Spanish Society of OphthalmoPediatrics, within the 93rd Congress of the SEO. Zaragoza, 2017.
  • “Drusen in the glaucoma patient. apropos of a case”. Parrilla Vallejo M; Rosselló Ferrer A; Ponte Zuñiga B; Cano Gómez MJ. Poster at the XII National Congress of the SEG, Valencia, 2017.
  • “EPNP with iridectomy and cataract surgery in plateau iris syndrome resistant to iridoplasty”. Ponte Zuñiga, B; Rosselló Ferrer A; Cano Gómez MJ; Muñoz Schiattino. Poster at the XII National Congress of the SEG. Valencia, 2017.
  • “XEN45 in glaucoma due to essential iris atrophy. apropos of a case”. Ponte Zuñiga, B; Rosselló Ferrer A; Cano Gómez MJ; Muñoz Schiattino. Poster at the XII National Congress of the SEG. Valencia, 2017.
  • “Quantification of foveal avascular zone in papilledema due to secondary intracranial hypertension”. Ainhoa Rosselló Ferrer, Antonio Manuel Garrido Hermosilla, María Jesús Díaz Granda. Poster P3 at the EURETINA Congress. Barcelona, 2017.
  • “OCT of ganglion cells in the study of chronic glaucoma: a case report”. Rosselló Ferrer, A; Parrilla Vallejo M; Domínguez Serrano B, Cano Gómez MJ. Poster at the 49th Congress of the SAO. Cadiz, 2016.
  • “Overcoming difficulties”. Molina Solana, P, Rosselló Ferrer, A, Pera Pérez, R, Gessa Sorroche, M. Poster at the 49th SAO Congress. Cadiz, 2016.
  • “Extirpation and closure by granulation in palpebraltumor “. Rosselló Ferrer A, Gessa Sorroche M, Alcántara Peña, A. Poster at the XXVI Congress of the S.E.CP.O.O. Bilbao, 2016.
  • “Orbital exenteration without eyelid preservation for infiltrating squamous cell carcinoma”. Rosselló Ferrer A, Gessa Sorroche M, Alcántara Peña, A. Poster at the XXVI Congress of the S.E.CP.O.O. Bilbao, 2016.
  • “Idiopathic posterior scleritis”. Rosselló Ferrer A, Gessa Sorroche M, Alcántara Peña, A. Poster at the XXVI Congress of the S.E.CP.O.O. Bilbao, 2016.
  • “Comparison of patients with contact lenses vs refractive surgery”. Rafael Perea Pérez, Manuel Caro Magdaleno, Sybella Muñoz Schiattino and Ainhoa Rosselló Ferrer. Oral communication at the 34th Congress of the Spanish Society of Contactology, during the 92nd SEO Congress. Málaga, 2016.
  • “The aggressiveness of conjunctival melanoma. Three case studies.” P65. Rosselló Ferrer A, Perea Pérez R, Díaz Ruíz C, Gessa Sorroche M, Ángeles Figueroa R. 47th Congress of the SAO. Seville, 2015.
  • “Woody conjunctivitis: Evolution after 14 months of treatment” Gessa Sorroche M.; Díaz Ruíz C; Rosselló Ferrer A. XLVII Congress of the SAO. Seville, 2015.
  • “Wedge resection of the trichiasic lamella.” P64. Rosselló Ferrer A, Díaz Ruíz C, Quintana Barriga L, Ángeles Figueroa R. 47th Congress of the SAO. Seville, 2015.
  • “Eyebrow transplant to correct post-traumatic eyelash defect” P98. Gessa Sorroche, M, Díaz Ruiz C, Rosselló Ferrer A, Ángeles Figueroa R. 47th Congress of the SAO. Seville, 2015.
  • “Behçet syndrome and pregnancy.” P61 Perea Pérez R, Sosa Domínguez D, Rosselló Ferrer A, López Navarrete E. 47th Congress of the SAO. Seville, 2015.
  • “Squamous cell carcinoma of the cornea: a case report.” P91. Quintana Barriga I, Mataix Albert B, Caro Magdaleno M, Rosselló Ferrer A. 47th Congress of the SAO. Seville, 2015.
  • Participation as a collaborating researcher in the Verisyse/Artisan Multicenter Retropupillary Study, led by Dr. Zarranz Ventura, Hospital Clínic de Barcelona, 2017.
  • Participation as a collaborating researcher in Project 2015-135-1/Prospective multicenter epidemiological study of the progression of geographic atrophy secondary to age-related macular degeneration. PROXIMA Study.
  • Participation as a collaborating researcher in Project 2015-098-1/Prospective multicenter epidemiological study of the progression of geographic atrophy secondary to age-related macular degeneration.
  • Participation as a collaborating researcher in Project 2017-305-1/Double-blind study of SYL1001 in patients with moderate to severe xerophthalmia.
  • Participation as a collaborating researcher in Project 2017-156-1/ Prospective, double-blind, randomized, multicenter, active comparator, parallel-group study, lasting 6 months, to evaluate the safety and ocular hypotensive efficacy of PG324 ophthalmic solution compared to Ganfort® (bimatoprost 0.03% / timolol 0.5%) ophthalmic solution in subjects with elevated intraocular pressure (MERCURY 3).
  • Participation, as a Research Collaborator at the Virgen Macarena Hospital, in the Phase I/II Academic Clinical Trial entitled “Multicenter Clinical Trial to Evaluate the Safety and Feasibility of an Allogeneic Tissue-Engineered Drug (nanostructured artificial human cornea) in patients with advanced trophic corneal ulcers refractory to conventional (ophthalmological) treatment” with protocol code CAH/UIc/2010 and EudraCT: 2010-024290-40.
  • Participation in the GEM-BELA.VRd clinical trial: “Phase II, open-label, multicenter trial of belantamab mafoditin in combination with VRd for the treatment of newly diagnosed multiple myeloma patients who are candidates for transplantation,” 2021.
Languages

Spanish, Catalan, English.

MEDICAL TEAM
Specialist in
Close Menu
Skip to content
This site is registered on wpml.org as a development site. Switch to a production site key to remove this banner.

Digital kit programme funded by the Next Generation funds of the recovery and resilience mechanism